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Evidence for high risk of cerebral hemorrhage in chronic
dialysis patients
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Evidence for high risk of cerebral hemorrhage in chronic dialysis
patients. One-half of the total deaths in chronic dialysis patients are due
to cardiovascular disease; however, the precise incidence and relative
risk of those compared to normals are not known. Therefore, we sought
to determine the annual incidence of cardiovascular disease and relative
risk of those on chronic dialysis to the general population. Both the
general population (1.2 million, Census 1990) and chronic dialysis
patients (N = 1,609) in Okinawa, Japan were studied prospectively
from April, 1988, to March, 1991. Diagnosis of stroke was made by
symptoms and brain CT scan, and acute myocardial infarction was done
by changes in electrocardiogram and serum enzymes. The relative risk
(observed/expected ratio) was calculated by using the standardized
morbidity rate obtained in both sexes and age-class every 10 years in
the general population. Forty-one stroke (8 cerebral infarction, 31
cerebral hemorrhage, and 2 subarachnoid hemorrhage) and four acute
myocardial infarction cases were registered during the study period in
chronic dialysis patients. The incidence per 1,000 person-year was 11.5
in stroke, 2.2 in cerebral infarction, 8.7 in cerebral hemorrhage, 0.6 in
subarachnoid hemorrhage, and 1.1 in acute myocardial infarction. The
relative risk compared to normals was 5.2 in stroke, 2.0 in cerebral
infarction, 10.7 in cerebral hemorrhage, 4.0 in subarachnoid hemor-
rhage, and 2.1 in acute myocardial infarction. Cerebral hemorrhage
occurred at 10 years younger than that of the general population (P <
0.001) and was associated with high prevalence of hypertension and low
levels of serum albumin and cholesterol. Our results confirm the
importance of blood pressure control and nutritional status in chronic
dialysis patients.
Heart failure and stroke are the leading causes of death in
chronic dialysis patients [1—5]. Moreover, occasional severe
atherosclerotic changes in these patients make renal transplan-
tation impossible [6]. These observations may support the
notion of an acceleration of atherosclerosis in dialysis patients
[2]. However, many dialysis patients with cardiovascular dis-
ease already have identifiable heart disease prior to starting
hemodialysis [4, 51. Additionally, there is a selected population
of multiple risk factors established for the general population
such as hypertension, hyperlipidemia, glucose intolerance, hy-
peruricemia, and cigarette smoking [7]. Therefore, it is still
debatable whether chronic dialysis therapy may accelerate
atherosclerosis [8—10]. Nevertheless, the epidemiological evi-
Received for publication March 29, 1993
and in revised form July 1, 1993
Accepted for publication July 1, 1993
© 1993 by the International Society of Nephrology
dence, such as the accurate incidence and relative risk of
cardiovascular disease to normals, is not yet shown in chronic
dialysis patients.
Dialysis patients in Japan have little opportunity for renal
transplantation, therefore their number is ever increasing [3]. In
Okinawa, which consists of a number of subtropical islands,
people move less frequently than those living in other parts of
Japan. This is true for dialysis patients as well. Accordingly, in
cases of stroke or myocardial infarction such patients are
ordinarily admitted and transferred to a hospital exclusively in
Okinawa.
Against this background, this study was designed to prospec-
tively examine the incidence of cardiovascular disease in the
general population and chronic dialysis patients simulta-
neously. We focused on the incidence and relative risk of
cardiovascular disease to normals in dialysis patients.
Methods
The study population consisted of 1.2 million (Census, 1990)
for the general population and 1,609 dialysis patients in Oki-
nawa, Japan between April 1988 and March 1991. The annual
incidence of cardiovascular diseases in the general population
[lii and the demographics of dialysis population in our registry
[3] have been previously reported. The prevalent dialysis
patients on April 1, 1988 were 970: 381 females and 589 males.
Six hundred and thirty-nine (293 females and 346 males) pa-
tients were accepted for chronic dialysis during the observation
period. All of them survived at least one month on dialysis.
To obtain an accurate case ascertainment, we made regular
visits of at least four times a year to the 27 dialysis units which
cover the entire area of Okinawa. Reports of suspected stroke
or acute myocardial infarction were made by the physician in
charge of the patients. We reviewed the charts and registered
them according to the following diagnostic criteria. Diagnosis of
stroke was made by both clinical symptoms and brain CT scan
[11]. Brain CT scan was performed in 98.4% in the cases of
general population [11] and 100% in those of dialysis patients.
Acute myocardial infarction was diagnosed when it was con-
firmed by electrocardiogram and/or changes in serum enzymes
with the criteria used in the MONICA project [11].
The incidence of cardiovascular disease was calculated as the
total number of cases divided by the total observation period,
per 1,000 person-year. To obtain relative risk of cardiovascular
disease, we used the standardized morbidity rate (SMR) in each
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Age at start of study, years old
Mean
SEM
Female, N = 674
0—29
30—49
40—49
50—59
60—69
70—79
80—
Male, N = 935
0—29
30—39
40—49
50—59
60—69
70—79
80—
Duration of dialysis at start of dialysis, months
mean
SEM
range
Cause of renal failure
Chronic glomerulonephritis
Diabetes mellitus
Polycystic kidney disease
Systemic lupus erythematosus
Nephrosclerosis
Miscellaneous
Current status at April 1, 1991
Alive on dialysis
Died
Functioning graft
Transferred
Duration of observation, person-year
Female
Male
Total
506
0.4
67 (9.9%)
97 (14.4%)
108 (16.0%)
136 (20.2%)
152 (22.6%)
92 (13.6%)
22 (3.3%)
77 (8.2%)
196 (20.9%)
205 (21.9%)
224 (24.0%)
142 (15.2%)
69 (7.4%)
22 (2.4%)
58.9
0.2
1 to 180
1,033 (64.2%)
311 (19.3%)
37 (2.3%)
32 (2.0%)
84 (5.2%)
112 (7.0%)
1,305 (81.1%)
252 (15.7%)
37 (2.3%)
15 (0.9%)
1,533.2
2,042.9
3,576.1
sex and age-class in the general population in Okinawa. The
SMR, average of three years, was used and it was expressed per
1,000 person-year. Calculation of the relative risk was done by
the following formula: relative risk = observed number/ex-
pected number, where the expected number was obtained from
SMR and observation period. The observation period was the
sum of duration of dialysis during the study period in each sex
and age-class. It was calculated after the start of the study in
April 1, 1988 or at the beginning of dialysis until death, renal
transplantation, and transfer to other parts of Japan or April 1,
1991, whichever came first.
Statistical analysis was performed using the Student's t and
chi-square tests. Significance of the relative risk to normals was
tested by the Z distribution. Unless otherwise stated, all data
were expressed as mean SEM. The level of statistical signif-
icance was defined as P <0.05.
Results
Table 1 summarizes the characteristics of the 1,609 (674
female and 935 males) patients studied. At the start of study,
39.5% (female) and 25.0% (male) of the patients were 60 years
and over. Causes of renal failure were distributed as: 64.2%
chronic glomerulonephritis, 19.3% diabetes mellitus, 2.3%
polycystic kidney disease, 2.0% systemic lupus erythematosus,
5.2% nephrosclerosis, and 7.0% miscellaneous diseases. At the
end of the study 81.1% of the patients were alive on dialysis and
15.7% died. Drop-out due to renal transplantation and transfer
was 2.3% and 0.9%, respectively. No cardiovascular disease
was found in patients with renal transplantation after the
surgery. The total observation period (person-year) was 3,576.1
(1,533.2 in female and 2,042.9 in male). The death rate was
70.47 per 1,000 patient-year.
Table 2 shows the incidence and the relative risk (O/E ratio)
of cardiovascular disease in chronic dialysis patients. The
incidence per 1,000 person-year was 11.5 (stroke), 2.2 (cerebral
infarction), 8.7 (cerebral hemorrhage), 0.6 (subarachnoid hem-
orrhage), and 1.1 (acute myocardial infarction). The relative
risk compared to normals was 5.2 (stroke), 2.0 (cerebral infarc-
tion), 10.7 (cerebral hemorrhage), 4.0 (subarachnoid hemor-
rhage), and 2.1 (acute myocardial infarction). The relative risk
of cerebral hemorrhage was significant, P < 0.001, and accord-
ingly that of stroke, P <0.001.
Table 3 shows the mean age (sEM) at onset of the cardiovas-
cular disease. Cerebral hemorrhage occurred at a mean age of
57.5 (3.6) years old in females and 50.0 (3.0) years old in males
who were significantly younger, and 9.4 years in female (P <
Table 1. Characteristics of dialysis patients in Okinawa, Japan during
the observation period between April 1, 1988 through March 31, 1991
(N = 1,609)
Table 2. Incidence and relative risk (O/E ratio) of cardiovascular
disease in chronic dialysis patients
Stroke CI CH SAH AMI
Female
Observed number (0) 14 2 11 1 I
Incidence 9.1 1.3 7.2 0.7 0.7
Expected number (E) 2.8 1.3 1.0 0.3 0.5
O/E ratio 5.0 1.6 11.3 2.9 2.0
Male
Observed number (0) 27 6 20 1 3
Incidence 13.4 2.9 9.8 0.5 1.5
Expected number (E) 5.1 2.7 1.9 0.2 1.4
O/E ratio 5.3 2.3 10.6 4.4 2.1
All
Observed number (0) 41 8 31 2 4
Incidence 11.5 2.2 8.7 0.6 1.1
Expected number (E) 7.9 4.2 2.9 0.5 1.9
O/E ratio 5.2a 2.0 lO.7a 4.0 2.1
Abbreviations are: CI, cerebral infarction; CH, cerebral hemorrhage;
SAH, subarachnoid hemorrhage; AMI, acute myocardial infarction.
Incidence was expressed per 1,000 person-year.
a P < 0.001
Table 3. Age at onset of the cardiovascular disease in chronic
dialysis patients
Female Male All
Stroke 58.6 3.la 53.6 2.7 55.3 21d
Cerebral infarction 56.0 2.8 65.3 4.1 63.0 3.4
Cerebral hemorrhage 57,5 36b 50.0 3,0c 52.6 24d
Subarachnoid hemorrhage 75.0 57.0 66.0 6.4
Myocardial infarction 66.0 58.6 0.3 60.5 1.6
Data are mean SEM. Significance was tested by Student's r-test
using the data from the general population [11].
a P < 0.001 and b P < 0.02 compared to female normals
P < 0.001 compared to male normals
d P < 0.001 and eP < 0,05 compared to all normals
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Table 4. Characteristics of 31 cases of cerebral hemorrhage
Case
Sex/
age
Dialysis
months
Renal
disease Drugs
TChol
mg/dl
Albumin
gf dl Comments
I
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
M/35
Ff52
M/54
M/29
Mf38
F/45
Mf46
M156
Ff61
Ff63
Ff57
MJ55
Ff36
Ff58
Ff74
Mf39
M/54
M/39
Mf60
M164
M135
Ff68
Ff44
Mf28
M169
M158
M/53
Mf65
Mf46
Ff75
M176
32
11
101
69
15
99
67
8
139
40
91
20
2
86
2
16
85
48
27
5
124
7
88
159
14
20
57
2
36
42
4
DM
NScI
CGN
CGN
CGN
CON
CON
CGN
CON
DM
CGN
CON
DM
CON
CGN
PKD
CGN
DM
DM
CON
CGN
CON
CON
CGN
CGN
CON
DM
NScI
CON
CON
CGN
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
No
Yes
No
Yes
Yes
No
No
169
188
129
144
270
200
166
208
113
230
243
106
208
224
96
153
225
161
127
197
106
118
167
126
168
206
71
144
203
168
190
4,1
3.6
4.3
3.9
4.7
4.1
3.9
2.9
3.9
4.6
3.9
3.9
3.6
3.4
3.8
4.0
3.8
3.5
3.2
3.5
3.2
3.9
4.0
3.6
3.6
3.5
3.9
3.6
5.3
3.6
3.4
died
alive
died
died
died
alive
alive
died
died
died
died 8 months later
died
died 5 months later
died
died
died
alive
alive
died
died
died
died
died
alive
alive
died
alive
alive
died
died
died
Mean
SEM
52.6
2.4
48.9
7.9
168.5
8.5
3.8
0.1
Abbreviations are: DM, diabetes mellitus; NScl, nephrosclerosis; CON, chronic glomerulonephritis; PKD, polycystic kidney disease; Drugs,
antihypertensive drugs; TChol, total cholesterol; died, died within 30 days of the incident, Comments denote patient status at April 1, 1992.
0.02) and 10.6 years in male (P < 0.001) than those of the
general population [11]. Other than cerebral hemorrhage, there
were no differences in age at onset between dialysis patients
and the general population.
Table 4 shows the characteristics of 31 patients (11 females
and 20 males) who had cerebral hemorrhage during the obser-
vation period. Mean (sEM) duration of hemodialysis was 48.9
(7.9) months, 2 to 159. Twenty-six patients (83.9%) were
receiving antihypertensive drugs. Mean (sEM) concentration of
total cholesterol and serum albumin were 168.5 (8.5) mg/dl and
3.8 (0.1) gIdl. Twenty patients (64.5%) died within 30 days of the
incident.
Discussion
When comparing the incidence with different populations, it
is important to take into account the effect of the selection bias.
A population of chronic dialysis patients can vary by the
difference in the rate of acceptance to chronic dialysis, renal
transplantation, and the patient's transfer. In our registry [3] the
acceptance rate was more than 160 per million population since
1988, and the rates of renal transplantation and transfer were
very small, less than 3%. For the reference, we have used the
average SMR obtained in the same area and same period in
three consecutive years in the general population [11].
The results may confirm the well-known observation in
chronic dialysis patients that the main causes of death are
cardiac and vascular in nature [l.-5J. In our registry they were
32.7% in cardiac, 12.4% in vascular, and 6.4% in sudden death
[31. However, there was a discrepancy between the incidence
and the death rate in cardiovascular diseases. We reviewed all
the charts of the death cases in which originally stroke or heart
failure was considered to be a cause of death. Only definite
cases were included in this study, and therefore our results may
underestimate the true incidence.
The incidence of stroke in chronic dialysis patients was
higher than the general population in Okinawa and that for
males of Japanese ancestry in Hawaii [12] and elsewhere [13].
Among the stroke victims cerebral hemorrhage was signifi-
cantly high. However, it is noteworthy that the incidence of
cerebral infarction and subarachnoid hemorrhage was not as
high compared to that of the general population.
The incidence of acute myocardial infarction was comparable
to that for the general population in Okinawa (Table 2). How-
ever, it was lower than earlier reports of the general population
[14, 15] and dialysis patients [2, 5, 10]. There were several cases
of sudden death at home and deceased upon arrival at the
hospital in our registry. We examined the medical records in
these cases carefully but were not able to obtain any evidence
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supporting the diagnostic criteria of myocardial infarction.
These cases were classified and registered as sudden death as in
the general population [11]. Since dialysis patients are under
intensive medical attention compared to the general population,
it is reasonable to assume that even slight symptoms stand a
better chance of detection than those in the general population.
The mean age of the patients with acute myocardial infarction in
the general population in Okinawa was 73.9 years old in female
and 62.5 years old in male [11]. Therefore, the relatively small
number of these aged groups in our dialysis registry may
explain the low incidence. It remains to be determined whether
the dialysis patients had severe myocardial infarction leading to
sudden death or a higher risk of myocardial infarction compared
to the general population.
Cerebral hemorrhage was observed at younger ages and had
a higher incidence than those of the general population. These
findings may be explained either by the high prevalence of risk
factors and/or by factors related to dialysis. Lindner et a! [2]
first reported the possibility of accelerating atherosclerosis and
the cumulative incidence increased concomitantly with the
length of dialysis. Thereafter, Rostand et al [10] and others [8,
9] challenged the notion and suggested the importance of
pre-existing disease prior to entering a dialysis program.
Dialysis patients exhibit a high prevalence of hypertension
immediately prior to initiating dialysis which is usually con-
trolled by strict control of volume excess [16]. However, some
remain hypertensive and may require antihypertensive drugs if
the volume control is inadequate. Among the dialysis patients,
actually 80.5% (33 of 41) in stroke and 83.9% (26 of 31) in
cerebral hemorrhage occurred in patients being prescribed
antihypertensive drugs (Table 4). In the cross sectional study,
the proportion of medication was about 52% in the total patients
of our registry [17]. It is not certain whether this rate is quite
high or low [18, 19]. Incidents, stroke and cerebral hemorrhage,
occurred significantly more in patients on antihypertensive
drugs (P < 0.001, chi-square test), whereas in the general
population the prevalence of hypertension was estimated as
70.8% for stroke and 79.0% for cerebral hemorrhage (unpub-
lished observations). Dialysis patients may be candidates for
more aggressive control of blood pressure than the general
population.
It is apparent that, as a group, patients with renal failure and
dialysis patients exhibit many of the signs and symptoms of
protein-calorie malnutrition [201. Protein intake in our dialysis
patients was about 40 to 80 g/day when they were taking 1.0 to
1.2 g/kg/day of protein as was recommended [21]. This value
was apparently lower than that for the general population in
Okinawa which averaged 75.6 grams per day in 1988 [22]. A
relatively poor nutritional status may exist in our dialysis
patients [17]. Indeed, levels of serum cholesterol and albumin
were rather low in cases of cerebral hemorrhage (Table 4).
Protein malnutrition has been ascribed to increase the incidence
of cerebral hemorrhage among both the general population [12,
13] and dialysis patients [23].
Dietary potassium supplementation reduced cerebral hemor-
rhage and death rates in stroke-prone spontaneously hyperten-
sive rats even though the blood pressure was not lowered [24,
25]. A direct and a protective effect on the endothelium was
speculated as the explanation for this [261. Obviously, dialysis
patients are under strict potassium restriction compared to the
general population. As such, they may be potassium depleted
and are contracting a high incidence of cerebral hemorrhage.
However, the clinical significance of potassium supplementa-
tion in humans is not yet clear [26] and should be withheld in
individuals such as dialysis patients with an imminent risk of
hyperkalemia.
Uremia per se could accelerate an atherogenic process [27,
28]. Accordingly, one may expect a higher survival rate with
better control of uremia. In fact, Charra et al [19] have reported
a good survival with dialysis of high KT/V. Conversely, a
shortened dialysis time increased the rate of mortality and
morbidity [29, 30]. Our dialysis population received dialysis for
three to five hours, twice or thrice weekly, and the gross annual
mortality rate has been around 7% [3, 17]. A prospective study
is needed to examine whether the high incidence of cerebral
hemorrhage is related to the amount of dialysis prescribed.
Use of heparin is essential for dialysis therapy but is hazard-
ous in case of cerebral hemorrhage. Actually, the size of the
lesion of cerebral hemorrhage tends to be larger than that in the
general population and probably leads to the poor prognosis in
dialysis patients [31]. In our patients, cerebral hemorrhage
occurred about 35.5 hours after the last dialysis, when the
effects of heparin have already disappeared. The clinical signif-
icance of heparin, therefore, remains to be determined.
In conclusion, the present study demonstrated that the inci-
dence and relative risk of cerebral infarction, subarachnoid
hemorrhage and acute myocardial infarction in chronic dialysis
patients were comparable to those of the general population.
However, the incidence and the relative risk of cerebral hem-
orrhage were significantly higher than those in the general
population. Cerebral hemorrhage occurred at younger ages and
was associated with a high prevalence of hypertension and low
levels of serum cholesterol and albumin. These results may
confirm the important role of hypertension [6] and nutritional
status as risk factors of cerebral hemorrhage among dialysis
patients.
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